{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:00:43Z","timestamp":1780632043875,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1053\/j.ajkd.2008.09.016","type":"journal-article","created":{"date-parts":[[2008,11,21]],"date-time":"2008-11-21T04:33:59Z","timestamp":1227242039000},"page":"133-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Nephrogenic Systemic Fibrosis Associated With Gadoversetamide Exposure: Treatment With Sodium Thiosulfate"],"prefix":"10.1053","volume":"53","author":[{"given":"Deepak","family":"Kadiyala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Roer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2008.09.016_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2215\/CJN.05721207","article-title":"Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis","volume":"3","author":"Reilly","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib2","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.ajkd.2007.12.036","article-title":"Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: A case-control study","volume":"51","author":"Kallen","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.09.016_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2310\/7070.2005.3067","article-title":"Sodium thiosulphate impairs the cytotoxic effects of cisplatin on FADU cells in culture","volume":"35","author":"Viallet","year":"2006","journal-title":"J Otolaryngol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2215\/CJN.03250906","article-title":"Nephrogenic systemic fibrosis: A mysterious disease in patients with renal failure\u2014Role of gadolinium-based contrast media in causation and the beneficial effect of IV sodium thiosulfate","volume":"2","author":"Yerram","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib5","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1093\/ndt\/gfn217","article-title":"Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis","volume":"23","author":"Marckmann","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.09.016_bib6","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxoedema-like cutaneous disease in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2008.09.016_bib7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.139.7.903","article-title":"Nephrogenic fibrosing dermopathy with systemic involvement","volume":"139","author":"Ting","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium: A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.09.016_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2006.10.048","article-title":"Gadolinium deposition in nephrogenic fibrosing dermopathy","volume":"56","author":"Boyd","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","article-title":"Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis","volume":"56","author":"High","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1067\/mjd.2003.78","article-title":"Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease)","volume":"48","author":"Mackay-Wiggan","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000077321","article-title":"Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis","volume":"208","author":"Lauchli","year":"2004","journal-title":"Dermatology"},{"key":"10.1053\/j.ajkd.2008.09.016_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.0303-6987.2004.00177.x","article-title":"A variant of nephrogenic fibrosing dermopathy with osteoclast-like giant cells: A syndrome of dysregulated matrix remodeling?","volume":"31","author":"Hershko","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2133.2005.06434.x","article-title":"Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis","volume":"152","author":"Gilliet","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archderm.143.8.1025","article-title":"Nephrogenic systemic fibrosis: Relationship to GBC and response to photopheresis","volume":"143","author":"Richmond","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.ajkd.2008.09.016_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1525-139X.2007.00407.x","article-title":"Treatment of nephrogenic systemic fibrosis: Limited options but hope for the future","volume":"21","author":"Linfert","year":"2008","journal-title":"Semin Dial"},{"key":"10.1053\/j.ajkd.2008.09.016_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1525-139X.2007.00399.x","article-title":"Nephrogenic systemic fibrosis: Early recognition and treatment","volume":"21","author":"Knopp","year":"2008","journal-title":"Semin Dial"},{"key":"10.1053\/j.ajkd.2008.09.016_bib18","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2215\/CJN.01520506","article-title":"Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults","volume":"1","author":"Araya","year":"2006","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608014248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608014248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:51:16Z","timestamp":1759456276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638608014248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0272638608014248"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.09.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephrogenic Systemic Fibrosis Associated With Gadoversetamide Exposure: Treatment With Sodium Thiosulfate","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}